Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00906347 · ClinicalTrials.gov registry record · Phase 4

A Trial of Oral Misoprostol for Labor Augmentation

A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
Phase 4
Development phase
350
Enrollment target

NCT00906347 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 350 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00906347, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
350 participants
Enrollment target

Study Summary

This is a prospective, randomized, controlled trial designed to examine the efficacy of oral misoprostol for labor augmentation compared to a standard regimen of intravenous oxytocin.

Interventions

  • DRUG Oxytocin
  • DRUG Misoprostol

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2008-12
Est. Completion 2011-01
Phase Phase 4

What the Registry Record Tells You About NCT00906347

The ClinicalTrials.gov registry entry for NCT00906347 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Oxytocin is the first listed.

NCT00906347 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00906347 about?

NCT00906347 is a clinical study titled "A Trial of Oral Misoprostol for Labor Augmentation". This is a prospective, randomized, controlled trial designed to examine the efficacy of oral misoprostol for labor augmentation compared to a standard regimen of intravenous oxytocin.

What is the current status of trial NCT00906347?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2008-12. Estimated completion is 2011-01.

What interventions are being tested in trial NCT00906347?

The interventions under investigation include: Oxytocin (DRUG), Misoprostol (DRUG).

Who is sponsoring clinical trial NCT00906347?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.